- Home
- EEX vs NAGE Comparison
EEX vs NAGE Comparison
Compare EEX & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EEX
- NAGE
- Stock Information
- Founded
- EEX 2013
- NAGE 1999
- Country
- EEX United States
- NAGE United States
- Employees
- EEX N/A
- NAGE N/A
- Industry
- EEX Advertising
- NAGE Medicinal Chemicals and Botanical Products
- Sector
- EEX Consumer Discretionary
- NAGE Health Care
- Exchange
- EEX Nasdaq
- NAGE Nasdaq
- Market Cap
- EEX 795.2M
- NAGE 766.4M
- IPO Year
- EEX 2017
- NAGE N/A
- Fundamental
- Price
- EEX $4.11
- NAGE $7.23
- Analyst Decision
- EEX Strong Buy
- NAGE Strong Buy
- Analyst Count
- EEX 1
- NAGE 3
- Target Price
- EEX $7.70
- NAGE $16.33
- AVG Volume (30 Days)
- EEX 52.1K
- NAGE 1.1M
- Earning Date
- EEX 10-31-2025
- NAGE 11-04-2025
- Dividend Yield
- EEX 1.46%
- NAGE N/A
- EPS Growth
- EEX N/A
- NAGE 1093.81
- EPS
- EEX 0.02
- NAGE 0.23
- Revenue
- EEX $437,500,000.00
- NAGE $124,709,000.00
- Revenue This Year
- EEX $17.23
- NAGE $29.51
- Revenue Next Year
- EEX $6.65
- NAGE $20.55
- P/E Ratio
- EEX $202.55
- NAGE $30.57
- Revenue Growth
- EEX 11.18
- NAGE 36.04
- 52 Week Low
- EEX $3.22
- NAGE $5.16
- 52 Week High
- EEX $5.45
- NAGE $14.69
- Technical
- Relative Strength Index (RSI)
- EEX 28.34
- NAGE 44.93
- Support Level
- EEX $3.95
- NAGE $6.61
- Resistance Level
- EEX $4.21
- NAGE $7.28
- Average True Range (ATR)
- EEX 0.22
- NAGE 0.43
- MACD
- EEX -0.03
- NAGE 0.07
- Stochastic Oscillator
- EEX 31.71
- NAGE 45.90
About EEX Emerald Holding Inc.
Emerald Holding Inc is a business-to-business (B2B) event organizer principally in the United States. The company is engaged in three complementary business lines; Connections division consists of a collection of B2B trade show franchises and other live events that provide exhibitors opportunities to engage with buyers and expand their brand's awareness in their industry; the Content division consists of B2B print publications and digital media products that complement existing trade show properties, and the Commerce division which offers software-as-a-service technology that enables year-round B2B buying and selling through Elastic Suite and Bulletin platforms for use by its customers. The Majority of the revenue for the company is generated from its Connections segment.
About NAGE Niagen Bioscience Inc. Common Stock
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.